Retinopathy Of Prematurity | sciencenewsnet.in

Breaking News

May is Mental Health Awareness Month. Experts and Patients Available for Interviews on Trending Issues

ChatGPT can be helpful for Black women’s self-education about HIV, PrEP

Tip Sheet: Funding awarded to two ovarian cancer research projects, progress towards liquid biopsies for lung cancer — and cannabis and alcohol use in patients

A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss

Mexican researchers have found that people who avoid going to psychologists choose the most violent suicide methods

Genetics, not lack of oxygen, causes cerebral palsy in quarter of cases

Leveraging Holocaust History to Influence Modern Healthcare Practice, Ethics

Gene Expression and Bioinformatics Tools to Optimize Cancer Therapy

OrthoInfo.org Offers Osteoporosis Awareness and Prevention Resources for Patients

Cedars-Sinai Physician-Scientist Leads Association of American Physicians

03 May, 2024

Non-Invasive Approach Predicts Retinopathy of Prematurity Earlier

June 29, 2023 sarah JonasResearch Results

Research from Ann & Robert H. Lurie Children’s Hospital of Chicago promises to spare many premature infants from undergoing invasive eye exams to detect retinopathy of prematurity (ROP), the most common cause of preventable lifelong blindness in children in the U.S.

Very low-dose Avastin effective for preventing blindness in preterm infants

April 23, 2020 sarah JonasResearch Results

Babies born prematurely who require treatment to prevent blindness from retinopathy of prematurity (ROP) could be treated with a dose of Avastin (bevacizumab) that is a fraction of the dose commonly used for ROP currently. Results from the dose-finding study were published April 23 in JAMA Ophthalmology. The study was conducted by the Pediatric Eye Disease Investigator Group (PEDIG) and supported by the National Eye Institute (NEI), part of the National Institutes of Health.